Table 4 Comparison of laboratory data between CHC patients with and without advanced liver fibrosis
Liver stiffness measurement |  < F3 (n = 15) |  ≥ F3 (n = 34) | p value |
|---|---|---|---|
ALT levels (U/L) | |||
 Week 0 | 56.7 ± 48.0 | 97.3 ± 60.9 | 0.027 |
 Week 24 | 15.4 ± 9.0 | 32.3 ± 21.9 | 0.006 |
 Week 48 | 14.3 ± 6.1 | 24.5 ± 10.0 | 0.001 |
P3NP levels (ng/mL) | |||
 Week 0 | 35.8 ± 12.1 | 49.0 ± 14.6 | 0.004 |
 Week 24 | 29.4 ± 13.4 | 38.7 ± 18.5 | 0.088 |
 Week 48 | 25.9 ± 5.9 | 39.3 ± 14.7 | 0.002 |
25(OH)VD levels (ng/mL) | |||
 Week 0 | 26.8 ± 9.1 | 21.9 ± 6.4 | 0.036 |
 Week 24 | 19.2 ± 6.7 | 19.7 ± 5.2 | 0.816 |
 Week 48 | 22.3 ± 8.0 | 19.4 ± 6.5 | 0.206 |